調査レポートカテゴリー： IT/電子, MarketsandMarkets, 世界, 医療/バイオ

Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024

世界の心臓安全サービス市場：種類別（スタンドアロン、統合）、サービス別（ECG /ホルター測定、血圧、心臓イメージング、徹底QT研究、その他のサービス）、エンドユーザー別（医薬品およびバイオ医薬品会社、CRO）

◆タイトル：Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024
◆商品コード：PH 7455
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年11月27日
◆ページ数：136
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：製薬
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥644,100見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥929,100見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarkets社は、心臓安全サービスの世界市場規模が2019年442百万ドルから2024年752百万ドルまで年平均11.2%成長すると予測しています。本書は、世界の心臓安全サービス市場について調査・分析し、市場概要、サービス別（ECG /ホルター測定、血圧、心臓イメージング、徹底QT研究、その他のサービス）分析、種類別（スタンドアロン、統合）分析、地域別分析、競合環境、企業概要などを掲載しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の心臓安全サービス市場：サービス別（ECG /ホルター測定、血圧、心臓イメージング、徹底QT研究、その他のサービス）
・世界の心臓安全サービス市場：種類別（スタンドアロン、統合）
・世界の心臓安全サービス市場：地域別
・競合環境
・企業概要
・付録

“The cardiac safety services market is projected to register a CAGR of 11.2% during the forecast period.”
The cardiac safety services market is projected to reach USD 752 million by 2024 from USD 442 million in 2019, at a CAGR of 11.2%. Growth in this industry is driven by the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increased outsourcing of R&D activities, and the increasing number of clinical trials. On the other hand, the high cost of cardiac safety evaluation is the burning issue in this market. In addition, the introduction of new technologies & methods and growth in the biosimilars and biologics market are offering growth opportunities for players in the market.

“The ECG/Holter measurement services segment is anticipated to grow at the fastest growth rate during the forecast period.”
The cardiac safety services market based on the type of service is categorized into ECG/Holter measurement, blood pressure measurement, cardiovascular imaging, thorough QT studies, and other services. The ECG/Holter measurement segment is expected to register the highest CAGR during the forecast period. The low cost of ECG/Holter measurement services and their wide usage in measuring cardiac activity are the key factors driving the growth of this market.

“The integrated services segment is estimated to dominate the market during the analysis period.”
By type, the cardiac safety services market is categorized into integrated and standalone services. The integrated services segment accounted for the largest share of the cardiac safety services market. The large share of this segment can be attributed to the benefits of bundled services to oversee end-to-end developments, as opposed to the specificity of standalone services. This helps reduce the time to market for manufacturers.

“The pharmaceutical & biopharmaceutical companies segment is estimated to grow at a rapid rate during the analysis period.”
Based on end user, the cardiac safety services market is segmented into pharmaceutical & biopharmaceutical companies and CROs. The pharmaceutical & biopharmaceutical companies segment is expected to be the fastest-growing segment of the global cardiac safety services market during the forecast period. Factors such as the stringent regulations for drug safety and increasing R&D activities to develop new drugs are driving the growth of this segment.

“North America is estimated to register the highest CAGR during the study period.”
Geographically, the cardiac safety services market was dominated by North America, followed by Europe in 2018. North Americ is estimated to grow at the fastest rate due to presence of major pharmaceutical & biopharmaceutical companies and the large number of clinical trials performed in the region.
Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
• By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
• By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%

Key players in the cardiac safety services market include Biotrial (France), Banook Group (France & Canada), Bioclinica (US), Certara L.P. (US), Celerion, Inc. (US), ERT, Inc. (US), Laboratory Corporation of America Holdings (US), Medpace Holdings, Inc. (US), Ncardia AG (Belgium), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon Inc. (China), SGS S.A. (Switzerland), BioTelemetry, Inc. (US), IQVIA (US), and Pharmaceutical Product Development LLC (US).

Research Coverage:
The report analyzes the cardiac safety services market by type of service, type, end user, and region. Apart from comprehensive geographic services analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the services portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use anyone, or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the services portfolios of the top players in the cardiac safety services market
• Services Development/Innovation: Detailed insights on the R&D activities, and services launches, partnerships & agreements in the cardiac safety services market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and services portfolios of the leading players in the cardiac safety services market
• Market Development: Detailed information about emerging markets. The report analyzes the market for various cardiac safety services across geographies
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the cardiac safety services market

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Market Size Estimation: Bottom-Up Approach
2.2.2 Market Size Estimation: Top-Down Approach
2.2.3 Growth Forecast
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 26)
4 Premium Insights (Page No. – 29)
4.1 Cardiac Safety Services Market Overview
4.2 North America: Market, By End User & Country (2018)
4.3 Market: Geographic Growth Opportunities
5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
5.2.1.2 Increased Outsourcing of R&D Activities
5.2.1.3 Increasing Number of Clinical Trials
5.2.2 Opportunities
5.2.2.1 Introduction of New Technologies and Methods
5.2.2.2 Growth in the Biosimilars and Biologics Markets
5.2.3 Challenges
5.2.3.1 High Cost of Cardiac Safety Evaluation
6 Cardiac Safety Services Market, By Type of Service (Page No. – 37)
6.1 Introduction
6.2 ECG/Holter Measurement Services
6.2.1 ECG/Holter Measurement Services Help in the R&D of Novel Methods for Clinical Trials and Drug Discovery
6.3 Blood Pressure Measurement Services
6.3.1 Increasing R&D Activities to Drive the Growth of the Blood Pressure Measurement Services Segment
6.4 Cardiovascular Imaging Services
6.4.1 Cardiovascular Imaging Services Help in Drug Evaluation
6.5 Thorough QT Studies
6.5.1 Need to Meet Stringent Regulatory Requirements is Driving the Demand for Thorough QT Studies
6.6 Other Services
7 Cardiac Safety Services Market, By Type (Page No. – 49)
7.1 Introduction
7.2 Integrated Services
7.2.1 Integrated Services Dominate the Market
7.3 Standalone Services
7.3.1 Standalone Services Segment Witnessing Growth Due to Cost-Effectiveness
8 Cardiac Safety Services Market, By End User (Page No. – 55)
8.1 Introduction
8.2 Pharmaceutical & Biopharmaceutical Companies
8.2.1 Increasing R&D By Pharmaceutical & Biopharmaceutical Companies to Drive the Demand for Cardiac Safety Services
8.3 Contract Research Organizations
8.3.1 Increasing Outsourcing of Drug Discovery Processes to Support the Growth of This End-User Segment
9 Cardiac Safety Services Market, By Region (Page No. – 61)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the Global Market for Cardiac Safety Services
9.2.2 Canada
9.2.2.1 Canada has High-Quality Clinical Trial Infrastructure and Expertise
9.3 Europe
9.3.1 Germany
9.3.1.1 Availability of Skilled Staff and Flexible Labor Laws Have Made Germany A Popular Hub in the Eu for Clinical Trials
9.3.2 UK
9.3.2.1 Steady Growth of Pharmaceutical R&D Expenditure Indicates Favorable Prospects for Cardiac Safety Services
9.3.3 France
9.3.3.1 A Large Number of Cancer Therapy-Focused Clinical Trials are Conducted in France
9.3.4 Italy
9.3.4.1 Italy’s Strong Pharma Industry and Availability of Funding for Drug Development Have Fueled Market Growth
9.3.5 Spain
9.3.5.1 Growing Investment in Pharmaceutical R&D and Favorable Climate for Approvals are Driving Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Dominates the APAC Market for Cardiac Safety Services
9.4.2 Japan
9.4.2.1 Strong Ip Rights and Supportive Policies Have Strengthened the R&D Sector in Japan
9.4.3 India
9.4.3.1 Lack of Language Barriers and Availability of Trained Resources Make India an Attractive Destination for Clinical Trials
9.4.4 Australia
9.4.4.1 Favorable R&D Tax Incentives and Cash Rebates Have Driven Clinical Trial Activity in Australia
9.4.5 Rest of Asia Pacific
9.5 Rest of the World
10 Competitive Landscape (Page No. – 98)
10.1 Overview
10.2 Market Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Services Launches & Upgrades
10.3.2 Expansions
10.3.3 Acquisitions
10.3.4 Partnerships, Alliances, and Agreements
10.3.5 Other Strategies
10.4 Competitive Leadership Mapping – Overall Market (2019)
10.4.1 Visionary Leaders
10.4.2 Dynamic Differentiators
10.4.3 Innovators
10.4.4 Emerging Companies
11 Company Profiles (Page No. – 105)
(Business Overview, Services Offered, Recent Developments, and MnM View)*
11.1 Bioclinica (A Subsidiary of Cinven)
11.2 Labcorp
11.3 BioTelemetry, Inc.
11.4 ERT, Inc.
11.5 Banook Group
11.6 IQVIA
11.7 Biotrial
11.8 Certara, L.P.
11.9 Celerion, Inc.
11.10 Medpace
11.11 Ncardia
11.12 Richmond Pharmacology
11.13 PhysioStim
11.14 Shanghai Medicilon Inc.
11.15 Pharmaceutical Product Development LLC
11.16 SGS S.A.
*Details on Business Overview, Services Offered, Recent Developments, and MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 129)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (108 Tables)
Table 1 R&D Expenditure & Percentage Change, By Company
Table 2 Market, By Type of Service, 2017–2024 (USD Million)
Table 3 ECG/Holter Measurement Services Market, By Region, 2017–2024 (USD Million)
Table 4 North America: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 5 Europe: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 6 Asia Pacific: ECG/Holter Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 7 Blood Pressure Measurement Services Market, By Region, 2017–2024 (USD Million)
Table 8 North America: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 9 Europe: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 10 Asia Pacific: Blood Pressure Measurement Services Market, By Country, 2017–2024 (USD Million)
Table 11 Cardiovascular Imaging Services Market, By Region, 2017–2024 (USD Million)
Table 12 North America: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 13 Europe: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 14 Asia Pacific: Cardiovascular Imaging Services Market, By Country, 2017–2024 (USD Million)
Table 15 Thorough QT Studies Market, By Region, 2017–2024 (USD Million)
Table 16 North America: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 17 Europe: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 18 Asia Pacific: Thorough QT Studies Market, By Country, 2017–2024 (USD Million)
Table 19 Other Cardiac Safety Services Market, By Region, 2017–2024 (USD Million)
Table 20 North America: Other Market, By Country, 2017–2024 (USD Million)
Table 21 Europe: Other Market, By Country, 2017–2024 (USD Million)
Table 22 Asia Pacific: Other Market, By Country, 2017–2024 (USD Million)
Table 23 Market, By Type, 2017–2024 (USD Million)
Table 24 Integrated Market, By Region, 2017–2024 (USD Million)
Table 25 North America: Integrated Cardiac Safety Services Market, By Country, 2017–2024 (USD Million)
Table 26 Europe: Integrated Market, By Country, 2017–2024 (USD Million)
Table 27 Asia Pacific: Integrated Market, By Country, 2017–2024 (USD Million)
Table 28 Standalone Market, By Region, 2017–2024 (USD Million)
Table 29 North America: Standalone Market, By Country, 2017–2024 (USD Million)
Table 30 Europe: Standalone Market, By Country, 2017–2024 (USD Million)
Table 31 Asia Pacific: Standalone Market, By Country, 2017–2024 (USD Million)
Table 32 Cardiac Safety Services Market, By End User, 2017–2024 (USD Million)
Table 33 Market for Pharmaceutical & Biopharmaceutical Companies, By Region, 2017–2024 (USD Million)
Table 34 North America: Cardiac Safety Services Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 35 Europe: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 36 Asia Pacific: Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2017–2024 (USD Million)
Table 37 Market for Contract Research Organizations, By Region, 2017–2024 (USD Million)
Table 38 North America: Cardiac Safety Services Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 39 Europe: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 40 Asia Pacific: Market for Contract Research Organizations, By Country, 2017–2024 (USD Million)
Table 41 Market, By Region, 2017–2024 (USD Million)
Table 42 North America: Market, By Country, 2017–2024 (USD Million)
Table 43 North America: Market, By Type of Service, 2017–2024 (USD Million)
Table 44 North America: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 45 North America: Market, By End User, 2017–2024 (USD Million)
Table 46 Total Number of Clinical Trials in the US (Till October 2019)
Table 47 Number of Clinical Trials Started in the Us, By Company, 2017
Table 48 US: Market, By Type of Service, 2017–2024 (USD Million)
Table 49 US: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 50 US: Market, By End User, 2017–2024 (USD Million)
Table 51 Number of Active Clinical Trials in Canada, By Condition (2019)
Table 52 Number of Active Clinical Trials in Canada, By Company, 2017
Table 53 Canada: Market, By Type of Service, 2017–2024 (USD Million)
Table 54 Canada: Market, By Type, 2017–2024 (USD Million)
Table 55 Canada: Market, By End User, 2017–2024 (USD Million)
Table 56 Europe: Market, By Country, 2017–2024 (USD Million)
Table 57 Europe: Cardiac Safety Services Market, By Type of Service, 2017–2024 (USD Million)
Table 58 Europe: Market, By Type, 2017–2024 (USD Million)
Table 59 Europe: Market, By End User, 2017–2024 (USD Million)
Table 60 Germany: Market, By Type of Service, 2017–2024 (USD Million)
Table 61 Germany: Market, By Type, 2017–2024 (USD Million)
Table 62 Germany: Table 63 UK: Market, By Type of Service, 2017–2024 (USD Million)
Table 64 UK: Market, By Type, 2017–2024 (USD Million)
Table 65 UK: Market, By End User, 2017–2024 (USD Million)
Table 66 Number of Clinical Trials Started in France, By Company, 2017
Table 67 France: Market, By Type of Service, 2017–2024 (USD Million)
Table 68 France: Market, By Type, 2017–2024 (USD Million)
Table 69 France: Market, By End User, 2017–2024 (USD Million)
Table 70 Number of Clinical Trials Started in Italy, By Company, 2017
Table 71 Italy: Market, By Type of Service, 2017–2024 (USD Million)
Table 72 Italy: Market, By Type, 2017–2024 (USD Million)
Table 73 Italy: Market, By End User, 2017–2024 (USD Million)
Table 74 Spain: Market, By Type of Service, 2017–2024 (USD Million)
Table 75 Spain: Market, By Type, 2017–2024 (USD Million)
Table 76 Spain: Market, By End User, 2017–2024 (USD Million)
Table 77 RoE: Market, By Type of Service, 2017–2024 (USD Million)
Table 78 RoE: Market, By Type, 2017–2024 (USD Million)
Table 79 RoE: Market, By End User, 2017–2024 (USD Million)
Table 80 Clinical Trials in the Asia Pacific, By Therapeutic Area, 2017
Table 81 APAC: Market, By Country, 2017–2024 (USD Million)
Table 82 APAC: Market, By Type of Service, 2017–2024 (USD Million)
Table 83 APAC: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 84 APAC: Market, By End User, 2017–2024 (USD Million)
Table 85 China: Market, By Type of Service, 2017–2024 (USD Million)
Table 86 China: Market, By Type, 2017–2024 (USD Million)
Table 87 China: Market, By End User, 2017–2024 (USD Million)
Table 88 Japan: Market, By Type of Service, 2017–2024 (USD Million)
Table 89 Japan: Market, By Type, 2017–2024 (USD Million)
Table 90 Japan: Market, By End User, 2017–2024 (USD Million)
Table 91 India: Market, By Type of Service, 2017–2024 (USD Million)
Table 92 India: Cardiac Safety Services Market, By Type, 2017–2024 (USD Million)
Table 93 India: Market, By End User, 2017–2024 (USD Million)
Table 94 Australia: Market, By Type of Service, 2017–2024 (USD Million)
Table 95 Australia: Market, By Type, 2017–2024 (USD Million)
Table 96 Australia: Market, By End User, 2017–2024 (USD Million)
Table 97 RoAPAC: Market, By Type of Service, 2017–2024 (USD Million)
Table 98 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 99 RoAPAC: Market, By End User, 2017–2024 (USD Million)
Table 100 RoW: Market, By Type of Service, 2017–2024 (USD Million)
Table 101 RoW: Market, By Type, 2017–2024 (USD Million)
Table 102 RoW: Market, By End User, 2017–2024 (USD Million)
Table 103 Global Cardiac Safety Services Market Player Ranking, 2018
Table 104 Service Launches & Upgrades, 2016–2019
Table 105 Expansions, 2016–2019
Table 106 Acquisitions, 2016–2019
Table 107 Partnerships, Alliances, and Agreements, 2016–2019
Table 108 Other Strategies, 2016– 2019


List of Figures (32 Figures)

Figure 1 Cardiac Safety Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Type of Service, 2019 Vs. 2024 (USD Million)
Figure 8 Market, By Type, 2019 Vs. 2024 (USD Million)
Figure 9 Market, By End User, 2019 Vs. 2024 (USD Million)
Figure 10 Market, By Region, 2019 Vs. 2024 (USD Million)
Figure 11 Increasing R&D Expenditure in the Pharmaceutical & Biotechnology Industry to Drive Market Growth
Figure 12 Pharmaceutical & Biopharmaceutical Companies Were the Largest End Users of Cardiac Safety Services in the North American Market in 2018
Figure 13 The US to Register the Highest Growth in the Cardiac Safety Services Market During the Forecast Period
Figure 14 Market: Drivers, Opportunities, and Challenges
Figure 15 Active Pharmaceutical Pipeline, January 2009 to January 2019
Figure 16 Total Number of Registered Studies (2005–2017)
Figure 17 Trial Count By Phase & Therapeutic Area, 2017
Figure 18 R&D Spending of Phrma Member Companies (USD Billion)
Figure 19 Total Number of Clinical Trials: Global Vs. North America (October 2019)
Figure 20 North America: Market Snapshot
Figure 21 UK: Pharmaceutical R&D Expenditure, 2013–2017
Figure 22 Spain: Pharmaceutical R&D Expenditure, 2011–2017
Figure 23 Clinical Trial Penetration: Developed Vs. Developing Countries, 2016
Figure 24 Asia Pacific: Market Snapshot
Figure 25 Service Launch and Upgradation—Key Growth Strategies Adopted By Market Players From 2016 to 2019
Figure 26 Competitive Leadership Mapping of the Cardiac Safety Services Market
Figure 27 Labcorp: Company Snapshot
Figure 28 BioTelemetry: Company Snapshot
Figure 29 IQVIA: Company Snapshot
Figure 30 MeDPAce: Company Snapshot
Figure 31 Ncardia: Company Snapshot
Figure 32 SGS S.A.: Company Snapshot

★調査レポート[世界の心臓安全サービス市場：種類別（スタンドアロン、統合）、サービス別（ECG /ホルター測定、血圧、心臓イメージング、徹底QT研究、その他のサービス）、エンドユーザー別（医薬品およびバイオ医薬品会社、CRO）] ( Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024 / PH 7455) 販売に関する免責事項
[世界の心臓安全サービス市場：種類別（スタンドアロン、統合）、サービス別（ECG /ホルター測定、血圧、心臓イメージング、徹底QT研究、その他のサービス）、エンドユーザー別（医薬品およびバイオ医薬品会社、CRO）] ( Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure, Cardiac Imaging, Thorough QT Study, Other Services), End User (Pharmaceutical & Biopharmaceutical Companies, CRO) - Global Forecast to 2024 / PH 7455) についてEメールでお問い合わせ
◆関連調査資料◆
  • 世界の滅菌装置市場：製品＆サービス別（機器（熱、低温）、消耗品＆付属品（指標、潤滑剤）、サービス（電子ビーム、ガンマ））、エンドユーザー別（病院＆クリニック、製薬会社）
    MD 2149 / MarketsandMarkets / 2019年11月29日 / MarketsandMarkets社は、滅菌装置の世界市場規模が2019年89億ドルから2024年125億ドルまで年平均7.0%成長すると予測しています。本書は、世界の滅菌装置市場について調査・分析し、市場概要、製品＆サービス別（滅菌器具、滅菌サービス、滅菌消耗品および付属品）分析、エンドユーザー別（病院・診療所、医療機器会社、製薬会社、食品・飲料会社、その他）分析、地域別分析、競合環境、企業概要などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の滅菌装置市場：製品＆サービス別（滅菌器具、滅菌サービス、滅菌消耗品および付属品） ・世界の滅菌装置市場：エンドユーザー別（病院・診療所、医療機器会社、製薬会社、食品・飲料会社、その他） ・世界の滅菌装置市場：地域別 ・競合環境...“The global sterilization equipment market size is projected to register a CAGR of 7.0% during the forecast period.” The global sterilization equipment market size is projected to reach USD 12.5 billion by 2024 from USD 8.9 million in 2019, at a CAGR of 7.0%. Growth in this industry is driven by the increasing number of surgeries performed, rising incidences of hospital-acquired infections, growth in the pharmaceutical and biotechnology industries, increasing outsourcing of sterilization services, and the growing focus on food sterilization and disinfection. On the other hand, harmful effects of ethylene oxide and end user non-compliance to sterilization standards are...
  • 世界の次世代シーケンシング（NGS）市場：製品別（NOVASEQ、NEXTSEQ、SEQUEL、NANOPORE）、消耗品別、バイオインフォマティクス別、サービス別（EXOME、RNA、DENOVO）、技術別（ION、SMRT）、 用途別（診断、がん）、エンドユーザー別、地域別
    BT 2697 / MarketsandMarkets / 2019年12月23日 / MarketsandMarkets社は、次世代シーケンシング（NGS）の世界市場規模が2019年78億ドルから2025年244億ドルまで年平均20.9%成長すると予測しています。本書は、世界の次世代シーケンシング（NGS）市場について調査・分析し、市場概要、製品＆サービス別（事前シーケンス製品＆サービス/サンプル準備、NGS消耗品、NGSプラットフォーム、NGSプラットフォーム向けサービス、シーケンスサービス、バイオインフォマティクス）分析、技術別（合成によるシーケンス、ION半導体シーケンス、単一分子リアルタイムシーケンス、ナノポアシーケンス、その他）分析、用途別（診断、薬物発見、農業および動物研究、その他）分析、エンドユーザー別（学術研究所＆研究センター、製薬＆バイオテクノロジー、病院＆クリニック、その他）分析、地域別分析、競合環境、企業概要などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の次世代シーケンシング（NGS）市場：製品＆サービス別（事前シーケンス製品＆サービス/サンプル準備、NGS消耗品、NGSプラットフォーム、NGSプラットフォーム向けサービス、シーケンスサービス、バイオインフォマティクス） ・世界の次世代シーケンシング（NGS）市場：技術別（合成によるシーケンス、ION半導体シーケンス、単一分子リアルタイムシーケンス、ナノポアシーケンス、その他） ・世界の次世代シーケンシング（NGS）市場：用途別（診断、薬物発見、農業および動物研究、その他） ・世界の次世代シーケンシング（NGS）市場：エンドユーザー別（学術研究所＆研究センター、製薬＆バイオテクノロジー、病院＆クリニック、その他）...“The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period.” The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. The NGS market is segmented based on application, technology, product & service, end user, and region. “The SBS segment accounted for the largest share of the NGS market in...
  • 心臓モニタリング＆心調律管理デバイスの世界市場予測：CM別、CRM別、エンドユーザー別
    MD1038 / MarketsandMarkets / 2019年10月30日 / MarketsandMarkets社は、心臓モニタリング＆心調律管理デバイスの世界市場規模が2019年207億ドルから2024年250億ドルまで年平均3.9%成長すると予測しています。当調査レポートでは、心臓モニタリング＆心調律管理デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、CM別（ECG、ILR、イベントモニター、MCT）分析、CRM別（除細動器（ICD（CRT D）、外部除細動器（AED））、ペースメーカー（CRT P、デュアルチャンバーペースメーカー））分析、エンドユーザー別（病院）分析、心臓モニタリング＆心調律管理デバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Increasing prevalence of CVD to drive the growth of this market.”The cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 25.0 billion by 2024 from USD 20.7 billion in 2019, at a CAGR of 3.9%. Growth in this market is primarily driven by the increasing incidence of cardiovascular diseases; technological advancements; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. However, the dearth of skilled professionals and frequent product recalls are expected to challenge market growth in the coming years “ILRs are expected to grow...
  • 世界の公共安全LTE市場：インフラストラクチャ別（E-UTRAN、EPC）、サービス別（コンサルティング、統合）、展開モデル別（プライベート、ハイブリッド）、用途別（法執行、消防サービス）、地域別
    SE 5575 / MarketsandMarkets / 2019年11月26日 / MarketsandMarkets社は、公共安全LTEの世界市場規模が2019年47億ドルから2024年117億ドルまで年平均20.2%成長すると予測しています。本書は、世界の公共安全LTE市場について調査・分析し、市場概要、インフラ＆サービス別（インフラ、サービス）分析、展開モデル別（プライベートLTE、コマーシャルLTE、ハイブリッドLTE）分析、用途別（法執行機関＆国境管理、救急医療サービス、消防サービス、災害管理）分析、エンドユーザー別（公安機関、産業、輸送、公益事業）分析、地域別分析、競合環境、企業概要などを掲載しております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界の公共安全LTE市場：インフラ＆サービス別（インフラ、サービス） ・世界の公共安全LTE市場：展開モデル別（プライベートLTE、コマーシャルLTE、ハイブリッドLTE） ・世界の公共安全LTE市場：用途別（法執行機関＆国境管理、救急医療サービス、消防サービス、災害管理） ・世界の公共安全LTE市場：エンドユーザー別（公安機関、産業、輸送、公益事業）...“The PS-LTE market is projected to grow at a CAGR of 20.2% from 2019 to 2024.” The PS-LTE market is projected to grow from USD 4.7 billion in 2019 to USD 11.7 billion by 2024; it is expected to grow at a CAGR of 20.2% from 2019 to 2024. The adoption of LTE technology to eliminate the existing interconnectivity issues between different networks, increase in demand for unmanned vehicles globally, and seamless data connectivity offered by LTE technology are expected to drive the growth of the PS-LTE market during the forecast period. However, spectrum scarcity acts as a restraint for...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆